Skip to main content

Want a detailed portfolio tracker?

Greenwich LifeSciences (GLSI) P/E (2020 - 2026)

Greenwich LifeSciences (GLSI) P/E from Sep 25, 2020 to Jul 21, 2026. The TTM Greenwich LifeSciences (GLSI) P/E is -9.29. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Greenwich LifeSciences (GLSI)

YearP/EChange
2026-9.29-38.16%
2025-15.03+77.98%
2024-8.44-44.21%
2023-15.14-43.15%
2022-26.63-61.65%
2021-69.43-75.11%
2020-278.98N/A

Comparison Greenwich LifeSciences (GLSI) P/E with competitors

Greenwich LifeSciences (GLSI) P/E is -9.29.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.80%
FGENFibroGen Inc0.24-102.58%
CHRSCoherus Biosciences Inc0.85-109.13%
FBIOFortress Biotech Inc0.95-110.21%
ORMPOramed Pharmaceuticals Inc1.50-116.17%
AGENAgenus Inc3.01-132.38%
INVAInnoviva Inc3.15-133.93%
VXRTVaxart Inc3.55-138.19%
CRMDCorMedix Inc3.63-139.04%
CVACCureVac N.V.4.45-147.83%
SRPTSarepta Therapeutics Inc4.88-152.52%
ABEOAbeona Therapeutics Inc5.39-157.96%
ABUSArbutus Biopharma Corp5.60-160.20%
ZVRAZevra Therapeutics Inc5.89-163.34%
SPROSpero Therapeutics Inc6.23-167.01%
CGENCompugen Ltd6.31-167.93%
RIGLRigel Pharmaceuticals6.87-173.93%
SLXNSilexion Therapeutics Corp7.30-178.49%
OMEROmeros Corporation9.26-199.61%
AUPHAurinia Pharmaceuticals Inc9.58-203.12%
PLXProtalix BioTherapeutics Inc10.89-217.17%
ACADAcadia Pharmaceuticals Inc11.73-226.18%
TBPHTheravance Biopharma Inc12.26-231.92%
ADMAAdma Biologics Inc12.42-233.60%
HRMYHarmony Biosciences Holdings Inc13.82-248.68%
SABSSAB Biotherapeutics Inc14.14-252.08%
NAGENiagen Bioscience Inc14.82-259.42%
INCYIncyte Corp15.82-270.23%
REGNRegeneron Pharmaceuticals Inc15.86-270.59%
PBYIPuma Biotechnology Inc17.32-286.29%
CPRXCatalyst Pharmaceuticals Inc17.44-287.62%
EXELExelixis Inc17.54-288.68%
TGTXTG Therapeutics Inc18.97-304.04%
MDXGMimedx Group Inc20.55-321.11%
XOMAXOMA Royalty Corp22.87-346.10%
ARGXArgen X SE24.30-361.41%
CTMXCytomX Therapeutics Inc24.82-367.04%
XOMAOXOMA Royalty Corp25.34-372.68%
HALOHalozyme Therapeutics Inc25.62-375.68%
XOMAPXOMA Royalty Corp25.67-376.18%
VRTXVertex Pharmaceuticals Inc27.99-401.19%
RPRXRoyalty Pharma plc - Class A28.69-408.64%
SLNOSoleno Therapeutics Inc29.02-412.17%
ASNDAscendis Pharma A/S30.09-423.68%
LGNDLigand Pharmaceuticals Inc - Class B37.91-507.88%
APLSApellis Pharmaceuticals Inc39.02-519.82%
BMRNBiomarin Pharmaceutical Inc42.21-554.14%
KRYSKrystal Biotech Inc45.34-587.84%
ONCBeiGene Ltd69.54-848.16%
PHARPharming Group N.V.75.03-907.18%
TECHBio-Techne Corp101.96-1196.94%
VCELVericel Corp109.92-1282.61%
ALNYAlnylam Pharmaceuticals Inc117.96-1369.15%
GMABGenmab140.29-1609.35%
TLXTelix Pharmaceuticals Ltd162.15-1844.55%
CORTCorcept Therapeutics Inc212.86-2390.07%